Pharma

Your Article Summary

See Latest Articles

Teva completes enrollment for Laquinimod trial: 1,000 patients were recruited over for the Phase III trial
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/20/08

Teva Pharmaceutical Industries Ltd. and Active Biotech announced that they have completed patient enrollment in a Phase III clinical trial of Teva's Multiple Sclerosis treatment Laquinimod.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas
ARIAD Pharmaceuticals, 12/18/09

Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies
Investigational New Drugs, 12/18/09

Prognostic Factors in Idiopathic Pulmonary Fibrosis
The American Journal of the Medical Sciences, 12/17/09

 See all of Drug Trials